Kurzeder C - Search Results

1

Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, Kost M, Hammerschmidt W, Delecluse HJ. Janz A, et al. Among authors: kurzeder c. J Virol. 2000 Nov;74(21):10142-52. doi: 10.1128/jvi.74.21.10142-10152.2000. J Virol. 2000. PMID: 11024143 Free PMC article.

2

High level of transgene expression in primary chronic lymphocytic leukemia cells using helper-virus-free recombinant Epstein-Barr virus vectors.

Wendtner CM, Kurzeder C, Theiss HD, Kofler DM, Baumert J, Delecluse HJ, Janz A, Hammerschmidt W, Hallek M. Wendtner CM, et al. Among authors: kurzeder c. Exp Hematol. 2003 Feb;31(2):99-108. doi: 10.1016/s0301-472x(02)01019-6. Exp Hematol. 2003. PMID: 12591274 Free article.

3

Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors.

Wendtner CM, Kofler DM, Theiss HD, Kurzeder C, Buhmann R, Schweighofer C, Perabo L, Danhauser-Riedl S, Baumert J, Hiddemann W, Hallek M, Büning H. Wendtner CM, et al. Among authors: kurzeder c. Blood. 2002 Sep 1;100(5):1655-61. Blood. 2002. PMID: 12176885 Free article.

4

Efficient gene transfer of CD40 ligand into ovarian carcinoma cells with a recombinant adeno-associated virus vector.

Koppold B, Sauer G, Büning H, Hallek M, Kreienberg R, Deissler H, Kurzeder C. Koppold B, et al. Among authors: kurzeder c. Int J Oncol. 2005 Jan;26(1):95-101. Int J Oncol. 2005. PMID: 15586229

5

CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells.

Buhmann R, Kurzeder C, Rehklau J, Westhaus D, Bursch S, Hiddemann W, Haferlach T, Hallek M, Schoch C. Buhmann R, et al. Among authors: kurzeder c. Br J Haematol. 2002 Sep;118(4):968-75. doi: 10.1046/j.1365-2141.2002.03719.x. Br J Haematol. 2002. PMID: 12199774 Free article.

6

Chemotherapeutic agents enhance AAV2-mediated gene transfer into breast cancer cells promoting CD40 ligand-based immunotherapy.

Koppold B, Sauer G, Buening H, Hallek M, Kreienberg R, Deissler H, Kurzeder C. Koppold B, et al. Among authors: kurzeder c. J Cancer Res Clin Oncol. 2006 Dec;132(12):787-94. doi: 10.1007/s00432-006-0127-3. Epub 2006 Jun 23. J Cancer Res Clin Oncol. 2006. PMID: 16794829

7

Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells.

Sauer G, Kurzeder C, Grundmann R, Kreienberg R, Zeillinger R, Deissler H. Sauer G, et al. Among authors: kurzeder c. Oncol Rep. 2003 Mar-Apr;10(2):405-10. Oncol Rep. 2003. PMID: 12579280

8

New molecular targets of breast cancer therapy.

Sauer G, Deissler H, Kurzeder C, Kreienberg R. Sauer G, et al. Among authors: kurzeder c. Strahlenther Onkol. 2002 Mar;178(3):123-33. doi: 10.1007/s00066-002-0957-0. Strahlenther Onkol. 2002. PMID: 11962188 Review.

9

Immunotherapy and cancer vaccines in the management of breast cancer.

Sauer G, Kurzeder C, Heilmann V, Kreienberg R, Deissler H. Sauer G, et al. Among authors: kurzeder c. Curr Pharm Des. 2005;11(27):3475-83. doi: 10.2174/138161205774414547. Curr Pharm Des. 2005. PMID: 16248802 Review.

10

Molecular targets of ovarian carcinomas with acquired resistance to platinum/taxane chemotherapy.

Kurzeder C, Sauer G, Deissler H. Kurzeder C, et al. Curr Cancer Drug Targets. 2006 May;6(3):207-27. doi: 10.2174/156800906776842975. Curr Cancer Drug Targets. 2006. PMID: 16712458 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters